Sequential antiviral and iron chelation treatment in a teenage boy with congenital anemia, chronic hepatitis C, and secondary hemosiderosis.
Yap
Jason
J
Division of Gastroenterology/Hepatology/Nutrition, Hospital for Sick Children, Ontario, Canada.
O'Connor
Constance
C
Kirby
Melanie
M
Guindi
Maha
M
Roberts
Eva A
EA
D000293:Adolescent; D000740:Anemia / Q000150:complications / Q000151:congenital* / Q000188:drug therapy; D000998:Antiviral Agents / Q000627:therapeutic use*; D015913:Chelation Therapy; D003676:Deferoxamine / Q000627:therapeutic use; D005293:Ferritins / Q000097:blood; D006453:Hemoglobinopathies / Q000150:complications; D006486:Hemosiderosis / Q000188:drug therapy* / Q000209:etiology; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D012254:Ribavirin / Q000627:therapeutic use*; D017262:Siderophores / Q000627:therapeutic use
D000998:Antiviral Agents; D016898:Interferon-alpha; D017262:Siderophores; D012254:Ribavirin; D005293:Ferritins; D003676:Deferoxamine